Press Releases

The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing titled “Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies.” Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc. presented testimony at the hearing on enhancements to the capital markets that can increase access to investors and decrease unnecessary regulatory burdens for emerging biotech companies trading on the public market.

BIO Latin American Conference will bring together biotechnology executives, academics and investors from around the globe

Advances in commercial applications to be showcased at 2014 BIO World Congress in Philadelphia

The EXPIRE Act would extend tax credits that expired at the end of 2013, including several of importance to the biotechnology industry.

BIO 2014 to feature a first-time Digital Health Zone and Digital Health Forum

BIO analysis shows that waiting times for EPA approval of new biofuel production pathways under the Renewable Fuel Standard exceed 17 months on average.

The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR) funded early-stage biomedical companies in a newly-created Innovation Zone at the 2014 BIO International Convention®. The Innovation Zone companies, focused on drug discovery, diagnostics and other platform technologies, will have dedicated exhibit space and participate in BIO’s One-on-One Partnering™ system. Select companies will make presentations in the BIO Business Forum, the Convention’s business development platform.
 

If left unchanged, the Obama administration’s proposal to slash use of biofuels in 2014 would increase emissions of greenhouse gases next year, according to a new white paper from BIO.

The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF) commend Indiana Governor Mike Pence for signing legislation today designed to create a pathway for the substitution of interchangeable biologic medicines.

Borlaug, winner of the Nobel Peace Prize, the Congressional Gold Medal and the Presidential Medal of Freedom, led a global agricultural evolution through his research and advocacy for modern farming practices.  Known as the Father of the Green Revolution, Borlaug is credited with saving more than a billion people from starvation with the development of high-yield, disease-resistant crop varieties and modern agricultural systems.

Principles reaffirm and broaden biotech industry’s commitment to transparency, advancing research

Advanced biofuel producers will discuss the industry’s progress toward commercial reality during breakout sessions at the World Congress on Industrial Biotechnology, the Biotechnology Industry Organization announced today.  The World Congress will be held May 12-15, 2014, at the Pennsylvania Convention Center in Philadelphia. 

The Biotechnology Industry Organization (BIO) is pleased to announce that Jerry Flint, Ph.D., Vice President of Biotech Affairs and Regulatory for DuPont Pioneer has been elected Chair of the organization’s Food and Agriculture Section Governing Board. 

The Biotechnology Industry Organization (BIO) announced today Dr. Calestous Juma, Professor at the Harvard Kennedy School and Dr. Jim Murray, Professor at the University of California at Davis will deliver the keynote addresses at the 2014 BIO Livestock Biotech Summit.

New Forums to focus on orphan diseases, personalized medicine, regenerative medicine and vaccines.

The Biotechnology Industry Organization (BIO) named DuPont Chair & CEO Ellen Kullman as the recipient of its 2014 George Washington Carver Award for innovation in industrial biotechnology. Kullman is the first woman to receive the honor, which has been awarded annually since 2008.

BIO commended the Centers for Medicare & Medicaid Services (CMS) for announcing their decision to halt movement on several proposals in their Medicare Part D draft rule.

The Biotechnology Industry Organization (BIO) announces an exclusive line-up of high-level industry executives for its Plenary Program during BIO’s 11th Annual World Congress on Industrial Biotechnology. The world’s largest industrial biotechnology event will be held May 12 – 15, 2014, at the Pennsylvania Convention Center in Philadelphia. 

Many of the provisions included in this budget proposal would jeopardize the continued biotech research and development that is necessary to find cures and breakthrough medicines for patients living with debilitating and life-threatening diseases.